AAMC Calls Supreme Court Decision Good News for Patients
Washington, D.C., January 7, 2013—AAMC (Association of American Medical Colleges) President and CEO Darrell G. Kirch, M.D., issued the following statement today on the U.S. Supreme Court’s decision not to hear the final appeal in the Sherley, et al. v. Sebelius, et al. litigation concerning the federal funding of human Embryonic Stem Cell Research (hESC):
"The AAMC applauds the U.S. Supreme Court's ruling not to review lower court decisions allowing the National Institutes of Health (NIH) to fund human Embryonic Stem Cell (hESC) research. This is good news for patients. Research using hESCs conducted under rigorous ethical standards continues to offer great promise in the search for cures and treatments for a variety of intractable diseases. With the legislative, regulatory, and legal barriers cleared, we hope the promise of hESC research can now be realized.
We congratulate and thank the U.S. Department of Justice and the Coalition for the Advancement of Medical Research, of which AAMC is a founding member, for their persuasive and successful legal defense of the Administration's hESC policy and the NIH Stem Cell Guidelines."
The Association of American Medical Colleges is a not-for-profit association dedicated to transforming health care through innovative medical education, cutting-edge patient care, and groundbreaking medical research. Its members comprise all 145 accredited U.S. and 17 accredited Canadian medical schools; nearly 400 major teaching hospitals and health systems, including 51 Department of Veterans Affairs medical centers; and more than 80 academic societies. Through these institutions and organizations, the AAMC serves the leaders of America’s medical schools and teaching hospitals and their 148,000 faculty members, 83,000 medical students, and 115,000 resident physicians. Additional information about the AAMC and its member medical schools and teaching hospitals is available at www.aamc.org.
Senior Director, Strategic Communications